A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes

被引：0
|
作者：
Sultan Linjawi
Byung-Wan Lee
Ömür Tabak
Susanna Lövdahl
Shanti Werther
Salahedeen Abusnana
机构：
[1] Coffs Endocrine and Diabetes Service,Division of Endocrinology and Metabolism, Department of Internal Medicine
[2] Yonsei University College of Medicine,Internal Medicine Clinic
[3] Ministry of Health Istanbul Kanuni Sultan Suleyman Training and Research Hospital,undefined
[4] Novo Nordisk A/S,undefined
[5] Rashid Center for Diabetes and Research,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Basal–bolus; BIAsp 30; Stepwise insulin intensification; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1 / 11
页数：10
相关论文
共 50 条
  • [41] Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial
    Niskanen, Leo
    Leiter, Lawrence A.
    Franek, Edward
    Weng, Jianping
    Damci, Taner
    Munoz-Torres, Manuel
    Donnet, Jean-Paul
    Endahl, Lars
    Skjoth, Trine Vang
    Vaag, Allan
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2012, 167 (02) : 287 - 294
  • [42] Comparison of twice-daily injection of biphasic insulin Lispro and basal-bolus therapy in insulin naive patients with type 2 diabetes
    Yamada, Satoru
    Masuda, Haruka
    Kitaoka, Akira
    Shiono, Kaoru
    Atsuda, Koichiro
    Irie, Junichiro
    Shimada, Akira
    DIABETES, 2007, 56 : A537 - A538
  • [43] Comparison of thrice daily biphasic human insulin (30/70) versus basal detemir & bolus aspart in patients with poorly controlled type 2 diabetes mellitus - A pilot study
    Shanmugasundar, G.
    Bhansali, Anil
    Walia, Rama
    Dutta, Pinaki
    Upreti, Vimal
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2012, 135 (01) : 78 - 83
  • [44] Treatment Intensification by Stepwise Addition of Prandial Insulin Aspart to Once-Daily Basal Insulin Detemir in Subjects with Type 2 Diabetes: The STEPwise™ Trial
    Meneghini, Luigi F.
    Hermansen, Kjeld
    Mersebach, Henriette
    Svendsen, Anne Louise
    Kumar, Sudhesh
    DIABETES, 2010, 59 : A199 - A199
  • [45] Insulin aspart compared to regular insulin and insulin lispro in basal bolus therapy with NPH to treat pediatric patients with type 1 diabetes mellitus
    Arslanian, S
    Foster, C
    Wright, NM
    Stender, S
    Hales, P
    Hale, D
    DIABETOLOGIA, 2005, 48 : A327 - A327
  • [46] Comparison of biphasic premixed insulin versus once daily basal insulin in insulin-naive veteran patients with type 2 diabetes
    Grisham-Takac, Catlin
    Yeary, Julianne
    Edwards, Krystal
    Chastain, Lisa
    Kelly, Kevin C.
    PHARMACOTHERAPY, 2015, 35 (11): : E259 - E259
  • [47] Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China
    James L. Palmer
    Amélie Beaudet
    Jeremy White
    Juliette Plun-Favreau
    Jayne Smith-Palmer
    Advances in Therapy, 2010, 27 : 814 - 827
  • [48] A COMPARISON OF BIPHASIC INSULIN ASPART (BIASP30) WITH BIPHASIC HUMAN INSULIN (BHI30) FOR TYPE 2 DIABETES MELLITUS IN REAL CLINICAL PRACTICE - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Wojciechowski, P.
    Gaweska, M.
    Caban, A.
    Jurkiewicz, B.
    Plisko, R.
    Rys, P.
    VALUE IN HEALTH, 2013, 16 (03) : A157 - A157
  • [49] Cost-Effectiveness of Biphasic Insulin Aspart versus Insulin Glargine in Patients with Type 2 Diabetes in China
    Palmer, James L.
    Beaudet, Amelie
    White, Jeremy
    Plun-Favreau, Juliette
    Smith-Palmer, Jayne
    ADVANCES IN THERAPY, 2010, 27 (11) : 814 - 827
  • [50] Cost-effectiveness of Biphasic insulin aspart 30 versus human premix insulin for type 2 diabetes patients in a polish setting
    Aristides, M.
    Kotchie, R.
    Nielsen, C.
    Valentine, W. J.
    Scheijbeler, H.
    VALUE IN HEALTH, 2007, 10 (06) : A261 - A261
12345